NCT01806415View on ClinicalTrials.gov

Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
DRUG

Fenobam

Oral administration of 50, 100, or 150mg of Fenobam or placebo (lactose)

DRUG

Placebo

Oral administration of placebo or lactose 150 mg

Trial Locations (1)

63110

Washington University School Of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01806415 - Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers | Biotech Hunter | Biotech Hunter